# \#aztrazeneca

**URL:** https://www.medboundhub.com/tag/aztrazeneca/693.md

[Latest](https://www.medboundhub.com/latest.md) · [Categories](https://www.medboundhub.com/categories.md) · [Tags](https://www.medboundhub.com/tags.md)

---

## [AstraZeneca’s Baxdrostat Scores in Resistant Hypertension](https://www.medboundhub.com/t/astrazeneca-s-baxdrostat-scores-in-resistant-hypertension/9467)

<div class="topic-metadata">

**Author:** [@Tejaswini\_15](https://www.medboundhub.com/u/Tejaswini_15)\
**Replies:** 3\
**Last updated:** [October 12, 2025, 5:30am UTC](https://www.medboundhub.com/t/astrazeneca-s-baxdrostat-scores-in-resistant-hypertension/9467 "2025-10-12T05:30:14Z")

</div>

Big news in the pharma sector: AstraZeneca’s experimental medicine, Baxdrostat, has hit its primary endpoint in Phase III testing for treatment-resistant hypertension. Main Points: –\> In a 12-week double-blind trial, p…